← Back to Analyst Consensus 
KRSA Buy
Korsana Biosciences, Inc.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 2 upgrades / ▼ 0 downgrades / 0 reiterations from 2 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 5, 2026 | Wedbush | initiate | — → Outperform | — | 58% |
| Sep 28, 2026 | Guggenheim | initiate | — → Buy | — | 52% |
| Sep 14, 2026 | Stifel | initiate | — → Buy | — | 53% |
| Sep 14, 2026 | TD Cowen | initiate | — → Buy | — | 54% |
| Sep 11, 2026 | UBS | initiate | — → Buy | — | 54% |
Price Target Trend
Sep 17, 2026 Latest: $44 Oct 25, 2026
EPS Estimates
0y $-1.70
Lo: $-1.70 Hi: $-1.70
1 analysts +1q $-0.67
Lo: $-0.67 Hi: $-0.67
1 analysts 0q —
+1y $-3.56
Lo: $-3.56 Hi: $-3.56
1 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days